American Academy of Ophthalmology: Week in Review
News of Retrotope’s recent rare pediatric disease designation for RT001 in INAD was included in AAO’s “Week in Review” roundup of key ophthalmic news. Did you know Retrotope also has a preclinical program in dry AMD? An IND filing for RT011 in this indication is expected in 2021.
https://www.aao.org/headline/week-in-review-epi-on-trial-dry-eye-drug-gold-cont